Health Catalyst Inc (FRA:2YP)

Q4 2024 Health Catalyst Inc Earnings Call Transcript

Feb 26, 2025 / 10:00 PM GMT

Release Date Price: €4.7 (-1.26%)

Transcript 10-K8-K

Key Points

Positve

Health Catalyst Inc (HCAT) reported total revenue of $307 million for 2024, with a 137% year-over-year growth in adjusted IA.
The technology segment showed strong performance with $195 million in revenue for the full year 2024, representing a 10% growth year-over-year for Q4.
The company successfully added 21 net new platform clients in 2024, with a significant portion coming from cross-selling to existing app clients.
Health Catalyst Inc (HCAT) received external recognitions, including being named a leader in Frost and Sullivan's 2024 US Population Health Management Report.
The company anticipates technology revenue to grow by 13% in 2025, driven by the momentum of the Ignite platform and cross-selling opportunities.

Negative

The net new platform client additions in 2024 were at the lower end of the expected revenue range, indicating potential challenges in client acquisition.
The transition to the Ignite platform may temporarily impact dollar-based retention rates, as increased app adoption does not always translate into proportional revenue increases.
Adjusted technology gross margin decreased by approximately 200 basis points in Q4 2024 due to initial deployment costs and Ignite migration headwinds.
Professional services revenue remained flat in Q4 2024, with lower than anticipated performance in certain segments.
The company plans to exit certain unprofitable ambulatory operations, which may impact professional services revenue in the short term.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

HCAT.OQ - Health Catalyst Inc
Q4 2024 Health Catalyst Inc Earnings Call
Feb 26, 2025 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
.

.

To all fights on hold, we appreciate your patience, and we ask that you please continue to stand by.

.

.

.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Please stand by. Your program is about to begin.

If you need assistance during your conference today, please press 0.

Welcome to the Health Catalyst 4th quarter and full year 2024 earnings conference call.

At this time, all participants have been placed in a listen-only mode, and the floor will be open for your questions following the presentation.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.